Serum lipid profile changes predict neurodegeneration in interferon-β1a-treated multiple sclerosis patients.
about
Fatty acid binding protein-4 is associated with disability in multiple sclerosis patients.Cardiovascular profile improvement during Natalizumab treatment.Metabolic Dysfunction and Peroxisome Proliferator-Activated Receptors (PPAR) in Multiple Sclerosis.The Role of Diet in Multiple Sclerosis: Mechanistic Connections and Current Evidence
P2860
Serum lipid profile changes predict neurodegeneration in interferon-β1a-treated multiple sclerosis patients.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Serum lipid profile changes pr ...... d multiple sclerosis patients.
@en
Serum lipid profile changes pr ...... d multiple sclerosis patients.
@nl
type
label
Serum lipid profile changes pr ...... d multiple sclerosis patients.
@en
Serum lipid profile changes pr ...... d multiple sclerosis patients.
@nl
prefLabel
Serum lipid profile changes pr ...... d multiple sclerosis patients.
@en
Serum lipid profile changes pr ...... d multiple sclerosis patients.
@nl
P2093
P2860
P50
P356
P1476
Serum lipid profile changes pr ...... ed multiple sclerosis patients
@en
P2093
Bianca Weinstock-Guttman
Eva Havrdova
Jan Krasensky
Kelly Fellows
Manuela Vaneckova
Murali Ramanathan
Niels Bergsland
Robert Zivadinov
Zdenek Seidl
P2860
P304
P356
10.1194/JLR.M072751
P577
2016-12-06T00:00:00Z